Amivantamab

ATC L01FX18 · 12 markets · 36 records

Amivantamab 12 markets · 36 records Forms
Filters
MarketAU 7US 5GB 5CA 5ES 5MX 2TW 2SG 1CN 1HK 1EU 1FR 1
Kind

AU 7 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 350 mg/7 mLinjectionRybrevant also in GB·SG·FR
  • 350 mginjectionRYBREVANT amivantamab 350 mg/7 mL concentrate for solution for infusion vial also in US·CN unknown
  • 3,520 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial also in ES unknown
  • 2,400 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial also in ES unknown
  • 1,600 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial also in ES unknown
  • 2,240 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Rybrevant ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 5 records · 5 shown of 5 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

  • 3,520 mg/22 mLinjection CombinationAmivantamab 3,520 mg/22 mL + Hyaluronidase (Human Recombinant) 44,000 mg/22 mLRybrevant Faspro
  • 2,400 mg/15 mLinjection CombinationAmivantamab 2,400 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 mg/15 mLRybrevant Faspro
  • 2,240 mg/14 mLinjection CombinationAmivantamab 2,240 mg/14 mL + Hyaluronidase (Human Recombinant) 28,000 mg/14 mLRybrevant Faspro
  • 1,600 mg/10 mLinjection CombinationAmivantamab 1,600 mg/10 mL + Hyaluronidase (Human Recombinant) 20,000 mg/10 mLRybrevant Faspro

GB 5 records · 5 shown of 5 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

CA 5 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

ES 5 records · 5 shown of 5 Source CIMA (AEMPS) · Data as of live

Only this ingredient

MX 2 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Rybrevant ×2Rybrevant Faspro ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 2 records · 2 shown of 2 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

Only this ingredient

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 350 mginjection锐珂埃万妥单抗 also in AU·US

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名RYBREVANT CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/7ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Rybrevant ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 350 mg/7 mLinjectionRYBREVANT 350 mg, solution à diluer pour perfusion also in AU·GB·SG
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.